Non-canonical transcriptional regulation of the poor prognostic factor UGT2B17 in chronic lymphocytic leukemic and normal B cellsBMC CANCERIF3.42024-04-020OAAI
Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survivalCLINICAL AND TRANSLATIONAL MEDICINEIF6.82023-11-302OAAI
A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor SignalosomeCELLSIF5.22023-05-023OAAI
UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathwaysCANCER LETTERSIF10.12023-01-016PRE
The Glycosyltransferase Pathway: An Integrated Analysis of the Cell MetabolomeMETABOLITESIF3.72022-10-213OAAI
UGT2B17 modifies drug response in chronic lymphocytic leukaemiaBRITISH JOURNAL OF CANCERIF6.82020-05-1817OAAI
Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progressionBRITISH JOURNAL OF CANCERIF6.82020-02-1213OAAI
Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patientsSCIENTIFIC REPORTSIF3.92019-09-1015OAAI
Inactivation of Prostaglandin E2 as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic LeukemiaFRONTIERS IN ONCOLOGYIF3.32019-07-0418OAAI
RPL28 promoter polymorphism rs4806668 is associated with reduced survival in FOLFIRI-treated metastatic colorectal cancer patientsCANCER RESEARCHIF16.62018-07-011PRE
Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal WomenFRONTIERS IN ENDOCRINOLOGYIF4.62018-03-1239OAAI
Divergent Expression and Metabolic Functions of Human Glucuronosyltransferases through Alternative SplicingCELL REPORTSIF6.92016-09-0122OAAI
The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer ProgressionEUROPEAN UROLOGYIF25.22016-04-0131PREAI
Profiling of Endogenous Estrogens, Their Precursors, and Metabolites in Endometrial Cancer Patients: Association with Risk and Relationship to Clinical CharacteristicsJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12011-02-0185OAAI